ABT Abbott Laboratories

NYSE
$110.51

Abbott Laboratories (ABT) is expected to report earnings on January 20, 2027, before the market open. The consensus earnings estimate is $1.64 per share, and the stock has had a Post-Earnings Announcement Drift (PEAD) of +9.1% since its last earnings release on October 21, 2026.

Abbott Laboratories Missed Expectations, Guides In-line
Wednesday, October 21, 2026 · 7:30 AM ET
Earnings Date
4th Quarter, Dec 2026
Jan 20
Wednesday · 7:30 AM ET
Earnings Whisper
-
vs $1.64
Rev est $13.15B
Volatility
Enter your expectations below to reveal the current volatility.
Trend Analysis
Expectation
Earnings
Price action
Signals
Score
Sentiment
Grade
Life Cycle
Call Analysis
Earnings-AVWAP $106.41

Sign in or subscribe to unlock sentiment, short interest, and technical indicators.

About Abbott Laboratories

Abbott Laboratories discovers, develops, manufactures and sells health care products. Its products include branded generic pharmaceuticals manufactured internationally, marketed and sold outside the United States.

Sector

Healthcare

Industry

Medical Instruments/Supply

Held By 7 ETFs, by dollar flow

Charts powered in part by Lightweight Charts™ by TradingView.